Table of Contents Author Guidelines Submit a Manuscript
Pulmonary Medicine
Volume 2018, Article ID 7056360, 7 pages
https://doi.org/10.1155/2018/7056360
Research Article

Pulmonary Arterial Hypertension Specific Therapy in Patients with Combined Post- and Precapillary Pulmonary Hypertension

1Section of Pulmonary Medicine, Department of Medicine, University of Manitoba, Winnipeg, MB, Canada
2Division of Cardiology, Department of Medicine, McGill University, Montreal, QC, Canada
3King Saud Bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, Jeddah, Saudi Arabia

Correspondence should be addressed to Zoheir Bshouty; ac.bm.csh@ytuohsbz

Received 24 October 2017; Revised 7 December 2017; Accepted 26 December 2017; Published 1 March 2018

Academic Editor: Dimitris Georgopoulos

Copyright © 2018 Hassan Alfraidi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. M. Hoeper, H. J. Bogaard, and R. Condliffe, “Definitions and diagnosis of pulmonary hypertension,” Journal of the American College of Cardiology, vol. 62, no. 25, pp. D42–D50, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. N. Galiè, M. Humbert, JL. Vachiery, S. Gibbs, I. Lang et al., “2015 ECS/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension,” European Heart Journal, vol. 37, no. 1, pp. 67–119, 2015. View at Google Scholar
  3. M. Guazzi and B. A. Borlaug, “Pulmonary hypertension due to left heart disease,” Circulation, vol. 126, no. 8, pp. 975–990, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. J.-L. Vachiéry, Y. Adir, J. A. Barberà et al., “Pulmonary hypertension due to left heart diseases,” Journal of the American College of Cardiology, vol. 62, no. 25, pp. D100–D108, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Naeije, J.-L. Vachiery, P. Yerly, and R. Vanderpool, “The transpulmonary pressure gradient for the diagnosis of pulmonary vascular disease,” European Respiratory Journal, vol. 41, no. 1, pp. 217–223, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Gerges, M. Gerges, M. B. Lang et al., “Diastolic pulmonary vascular pressure gradient: A predictor of prognosis in "out-of-proportion" pulmonary hypertension,” CHEST, vol. 143, no. 3, pp. 758–766, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. E. Tampakakis, P. J. Leary, V. N. Selby et al., “The diastolic pulmonary gradient does not predict survival in patients with pulmonary hypertension due to left heart disease,” JACC: Heart Failure, vol. 3, no. 1, pp. 9–16, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. H. P. Chaliki, D. G. Hurrell, R. A. Nishimura, R. A. Reinke, and C. P. Appleton, “Pulmonary venous pressure: Relationship to pulmonary artery, pulmonary wedge, and left atrial pressure in normal, lightly sedated dogs,” Catheterization and Cardiovascular Interventions, vol. 56, no. 3, pp. 432–438, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. R. K. Albert and W. J. E. Lamm, “Left atrial pressure can be accurately transmitted to the pulmonary artery despite Zone 1 conditions,” American Journal of Respiratory and Critical Care Medicine, vol. 167, no. 7, pp. 1016–1020, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. N. Saouti, N. Westerhof, P. E. Postmus, and A. Vonk-Noordegraaf, “The arterial load in pulmonary hypertension,” European Respiratory Review, vol. 19, no. 117, pp. 197–203, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. R. Ilsar, B. P. Bailey, T. A. Dobbins, and D. S. Celermajer, “The Relationship Between Pulmonary Artery and Pulmonary Capillary Wedge Pressure for the Diagnosis of Pulmonary Vascular Disease,” Heart, Lung and Circulation, vol. 19, no. 1, pp. 38–42, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. D. B. Badesch, G. E. Raskob, C. G. Elliott et al., “Pulmonary arterial hypertension: baseline characteristics from the REVEAL registry,” CHEST, vol. 137, no. 2, pp. 376–387, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. A. E. Frost, H. W. Farber, R. J. Barst, D. P. Miller, C. G. Elliott, and M. D. McGoon, “Demographics and outcomes of patients diagnosed with pulmonary hypertension with pulmonary capillary wedge pressures 16 to 18 mm Hg: Insights from the REVEAL registry,” CHEST, vol. 143, no. 1, pp. 185–195, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. R. M. Califf, K. F. Adams, W. J. McKenna, and et al, “A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: the Flolan International Randomized Survival Trial (FIRST),” American Heart Journal , vol. 134, no. 1, pp. 44–54, 1997. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Packer, J. McMurray, B. M. Massie et al., “Clinical effects of endothelin receptor antagonism with bosentan in patients with severe chronic heart failure: Results of a pilot study,” Journal of Cardiac Failure, vol. 11, no. 1, pp. 12–20, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. Z. Bshouty and M. Younes, “Distensibility and pressure-flow relationship of the pulmonary circulation. II. Multibranched model,” Journal of Applied Physiology, vol. 68, no. 4, pp. 1514–1527, 1990. View at Publisher · View at Google Scholar · View at Scopus
  17. Z. Bshouty, “Vascular compromise and hemodynamics in pulmonary arterial hypertension: Model predictions,” Canadian Respiratory Journal, vol. 19, no. 3, pp. e15–e17, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. “ATS statement: guidelines for the six-minute walk test,” American Journal of Respiratory and Critical Care Medicine, vol. 166, no. 1, pp. 111–117, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. P. L. Enright and D. L. Sherrill, “Reference equations for the six-minute walk in healthy adults,” American Journal of Respiratory and Critical Care Medicine, vol. 158, no. 5, part 1, pp. 1384–1387, 1998. View at Publisher · View at Google Scholar · View at Scopus
  20. M. M. Hoeper, I. Markevych, E. Spiekerkoetter, T. Welte, and J. Niedermeyer, “Goal-oriented treatment and combination therapy for pulmonary arterial hypertension,” European Respiratory Journal, vol. 26, no. 5, pp. 858–863, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. E. D. Flores, R. A. Lange, and L. D. Hillis, “Relation of mean pulmonary arterial wedge pressure and left ventricular end-diastolic pressure,” American Journal of Cardiology, vol. 66, no. 20, pp. 1532-1533, 1990. View at Publisher · View at Google Scholar · View at Scopus
  22. R. K. F. De Oliveira, E. V. M. Ferreira, R. P. Ramos et al., “Usefulness of pulmonary capillary wedge pressure as a correlate of left ventricular filling pressures in pulmonary arterial hypertension,” The Journal of Heart and Lung Transplantation, vol. 33, no. 2, pp. 157–162, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. N. R. Dayeh, J. Ledoux, and J. Dupuis, “Lung Capillary Stress Failure and Arteriolar Remodelling in Pulmonary Hypertension Associated with Left Heart Disease (Group 2 PH),” Progress in Cardiovascular Diseases, vol. 59, no. 1, pp. 11–21, 2016. View at Publisher · View at Google Scholar · View at Scopus
  24. J. B. West and O. Mathieu-Costello, “Vulnerability of pulmonary capillaries in heart disease,” Circulation, vol. 92, no. 3, pp. 622–631, 1995. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Farrero, I. Blanco, M. Batlle et al., “Pulmonary hypertension is related to peripheral endothelial dysfunction in heart failure with preserved ejection fraction,” Circulation: Heart Failure, vol. 7, no. 5, pp. 791–798, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. G. D. Lewis, R. Shah, K. Shahzad et al., “Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension,” Circulation, vol. 116, no. 14, pp. 1555–1562, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. P. Botha, G. Parry, J. H. Dark, and G. A. MacGowan, “Acute Hemodynamic Effects of Intravenous Sildenafil Citrate in Congestive Heart Failure: Comparison of Phosphodiesterase Type-3 and -5 Inhibition,” The Journal of Heart and Lung Transplantation, vol. 28, no. 7, pp. 676–682, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. D. Bonderman, S. Ghio, S. B. Felix et al., “Riociguat for patients with pulmonary hypertension caused by systolic left ventricular dysfunction: A phase IIb double-blind, randomized, placebo-controlled, dose-ranging hemodynamic study,” Circulation, vol. 128, no. 5, pp. 502–511, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Jiang, L. Wang, C.-T. Zhu et al., “Comparative effectiveness of sildenafil for pulmonary hypertension due to left heart disease with HFrEF,” Hypertension Research, vol. 38, no. 12, pp. 829–839, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. E. S. Hoendermis, L. C. Y. Liu, Y. M. Hummel et al., “Effects of sildenafil on invasive haemodynamics and exercise capacity in heart failure patients with preserved ejection fraction and pulmonary hypertension: A randomized controlled trial,” European Heart Journal, vol. 36, no. 38, pp. 2565–2573, 2015. View at Publisher · View at Google Scholar · View at Scopus
  31. E. Kaluski, G. Cotter, M. Leitman et al., “Clinical and hemodynamic effects of bosentan dose optimization in symptomatic heart failure patients with severe systolic dysfunction, associated with secondary pulmonary hypertension - A multi-center randomized study,” Cardiology, vol. 109, no. 4, pp. 273–280, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. C. Gerges, M. Gerges, N. Skoro-Sajer et al., “Hemodynamic thresholds for precapillary pulmonary hypertension,” CHEST, vol. 149, no. 4, pp. 1061–1073, 2016. View at Publisher · View at Google Scholar · View at Scopus
  33. T. Thenappan, S. J. Shah, S. Rich, L. Tian, S. L. Archer, and M. Gomberg-Maitland, “Survival in pulmonary arterial hypertension: A reappraisal of the NIH risk stratification equation,” European Respiratory Journal, vol. 35, no. 5, pp. 1079–1087, 2010. View at Publisher · View at Google Scholar · View at Scopus